Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis

ISSN： 1590-1874

Source： Neurological Sciences, Vol.31, Iss.2, 2010-11, pp. : 261-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Monoclonal Antibodies as Disease Modifying Therapy in Multiple Sclerosis

By Longbrake Erin Parks Becky Cross Anne

Current Neurology and Neuroscience Reports, Vol. 13, Iss. 11, 2013-11 ,pp. : 1-9

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive dysfunction in multiple sclerosis: The effect of pharmacological interventions

By Lyros Epameinondas Messinis Lambros Papageorgiou Sokratis G. Papathanasopoulos Panagiotis

International Review of Psychiatry, Vol. 22, Iss. 1, 2010-01 ,pp. : 35-42

Informa Healthcare

Access to resources Recommend Favorite

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis

By Dineen R. A.

Brain, Vol. 132, Iss. 1, 2009-01 ,pp. : 239-249

Oxford University Press

Access to resources Recommend Favorite

Cognitive impairment in multiple sclerosis

By Rao S.M.

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 53-53

Elsevier

Access to resources Recommend Favorite

Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: A descriptive study

By Drew Margaret

Archives of Clinical Neuropsychology, Vol. 23, Iss. 1, 2008-01 ,pp. : 1-19

Oxford University Press

Access to resources Recommend Favorite